Analyze Diet
Equine veterinary journal2010; 43(4); 494-499; doi: 10.1111/j.2042-3306.2010.00302.x

Effects of a supplement containing chromium and magnesium on morphometric measurements, resting glucose, insulin concentrations and insulin sensitivity in laminitic obese horses.

Abstract: Obesity and insulin resistance are risk factors for laminitis in equids and supplements containing chromium and magnesium might improve insulin sensitivity. Objective: A supplement containing chromium, magnesium and other nutraceuticals would alter morphometric measurements, blood variables, and insulin sensitivity in laminitic obese horses. Methods: Twelve previously laminitic obese (body condition score ≥ 7/9) horses were randomly allocated to treatment (n = 6) and control (n = 6) groups and 2 obese horses with clinical laminitis were included in the treatment group. Treated animals received 56 g supplement with 0.25 kg oats once daily for 16 weeks. The supplement contained chromium (5 mg/day as yeast), magnesium (8.8 g/day as oxide/proteinate), and other nutraceuticals. Insulin-modified frequently sampled i.v. glucose tolerance tests were performed with hay provided at 0, 8 and 16 weeks, and insulin sensitivity was estimated by minimal model analysis. Physical measurements were collected at the same points. Horses were not exercised. Results: Hyperinsulinaemia (>30 µu/ml) was detected in 12 of 14 horses prior to treatment. Glucose and insulin data from one mare with clinical laminitis were excluded because of persistent pain. Mean ± s.d. insulin sensitivity was 0.64 ± 0.62 × 10(-4) l/min/mu prior to treatment for the remaining 13 horses. Time and treatment × time effects were not significant for any of the variables examined, with the exception of resting insulin concentrations, which significantly increased over time (P = 0.018). Health status remained the same. Conclusions: The supplement containing chromium and magnesium evaluated in this study did not alter morphometric measurements, blood variables, resting insulin concentrations or insulin sensitivity in laminitic obese horses. Conclusions: Additional research is required to determine the appropriate use of chromium and magnesium supplements in horses.
Publication Date: 2010-09-29 PubMed ID: 21496075DOI: 10.1111/j.2042-3306.2010.00302.xGoogle Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
  • Journal Article
  • Randomized Controlled Trial

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

The research article is a study on the effects of a supplement with chromium and magnesium on laminitic obese horses with an evaluation of physical measurements and insulin sensitivity as indicators. However, the supplement did not show significant changes in the subjects.

Introduction

This study investigates the effects of chromium and magnesium, supplemented in the diets of obese horses previously suffering from laminitis, which is a painful condition affecting the horse’s hoof. Obesity and insulin resistance are established risk factors for this detrimental condition. The idea is that supplements rich in chromium and magnesium might help to improve insulin sensitivity. The experiment includes different measurements and tests that relate to the horse’s physical state and insulin indicators.

Methodology

  • The researchers involved a total of 14 horses in the study. Out of them, 12 were formerly laminitic and obese, who were then randomly divided into two groups – treatment and control, each containing 6 horses.
  • Additionally, 2 obese horses diagnosed with clinical laminitis were included only in the treatment group.
  • The horses in the treatment group were given 56 g of a supplement, along with 0.25 kg of oats once daily for a timeline of 16 weeks. The chosen supplement was a blend of chromium (5 mg/day as yeast), magnesium (8.8 g/day as oxide/proteinate), and other nutraceuticals.
  • To monitor the insulin sensitivity, insulin-modified frequently sampled intravenous glucose tolerance tests were executed at 0, 8 and 16 weeks, while the results were assessed by minimal model analysis.
  • Morphometric measurements of the horses were recorded alongside. Importantly, horses were kept unexercised throughout the study.

Results

  • Prior to the commencement of the study, hyperinsulinaemia, a condition characterized by excessive levels of insulin in the blood, was found in 12 out of the 14 participating horses.
  • However, due to persistent pain, the data from one mare with clinical laminitis was excluded.
  • As per the results, there wasn’t any significant change noticed over time in the measurements and variables examined in the horses, excluding the resting insulin concentrations that showed an increase.
  • The overall health status of the participating equids remained unchanged according to the records.

Conclusion

The evaluation revealed that the supplement containing chromium and magnesium didn’t alter the morphometric measurements, blood variables, resting insulin concentrations, or insulin sensitivity in the laminitic obese horses. Considering this, further research is needed to unearth the potential uses of supplements containing chromium and magnesium in horse diets and understand their impact better.

Cite This Article

APA
Chameroy KA, Frank N, Elliott SB, Boston RC. (2010). Effects of a supplement containing chromium and magnesium on morphometric measurements, resting glucose, insulin concentrations and insulin sensitivity in laminitic obese horses. Equine Vet J, 43(4), 494-499. https://doi.org/10.1111/j.2042-3306.2010.00302.x

Publication

ISSN: 2042-3306
NlmUniqueID: 0173320
Country: United States
Language: English
Volume: 43
Issue: 4
Pages: 494-499

Researcher Affiliations

Chameroy, K A
  • Department of Large Animal Clinical Sciences, College of Veterinary Medicine, University of Tennessee, Knoxville, TN, USA.
Frank, N
    Elliott, S B
      Boston, R C

        MeSH Terms

        • Animals
        • Aspartate Aminotransferases / blood
        • Blood Glucose / analysis
        • Cholesterol / blood
        • Chromium / administration & dosage
        • Dietary Supplements
        • Fatty Acids, Nonesterified / blood
        • Female
        • Foot Diseases / blood
        • Foot Diseases / diet therapy
        • Foot Diseases / metabolism
        • Foot Diseases / veterinary
        • Glucose Tolerance Test / veterinary
        • Horse Diseases / blood
        • Horse Diseases / diet therapy
        • Horse Diseases / metabolism
        • Horses
        • Insulin / blood
        • Insulin Resistance / physiology
        • Magnesium / administration & dosage
        • Male
        • Obesity / blood
        • Obesity / diet therapy
        • Obesity / metabolism
        • Obesity / veterinary
        • Triglycerides / blood
        • gamma-Glutamyltransferase / blood

        Citations

        This article has been cited 9 times.
        1. Satué K, Miguel-Pastor L, Chicharro D, Gardón JC. Hepatic Enzyme Profile in Horses. Animals (Basel) 2022 Mar 29;12(7).
          doi: 10.3390/ani12070861pubmed: 35405850google scholar: lookup
        2. Leschke DH, Muir GS, Hodgson JK, Coyle M, Horn R, Bertin FR. Immunoreactive insulin stability in horses at risk of insulin dysregulation. J Vet Intern Med 2019 Nov;33(6):2746-2751.
          doi: 10.1111/jvim.15629pubmed: 31617618google scholar: lookup
        3. Schedlbauer C, Blaue D, Gericke M, Blüher M, Starzonek J, Gittel C, Brehm W, Vervuert I. Impact of body weight gain on hepatic metabolism and hepatic inflammatory cytokines in comparison of Shetland pony geldings and Warmblood horse geldings. PeerJ 2019;7:e7069.
          doi: 10.7717/peerj.7069pubmed: 31211018google scholar: lookup
        4. Durham AE, Frank N, McGowan CM, Menzies-Gow NJ, Roelfsema E, Vervuert I, Feige K, Fey K. ECEIM consensus statement on equine metabolic syndrome. J Vet Intern Med 2019 Mar;33(2):335-349.
          doi: 10.1111/jvim.15423pubmed: 30724412google scholar: lookup
        5. Michalak I, Mironiuk M, Marycz K. A comprehensive analysis of biosorption of metal ions by macroalgae using ICP-OES, SEM-EDX and FTIR techniques. PLoS One 2018;13(10):e0205590.
          doi: 10.1371/journal.pone.0205590pubmed: 30321205google scholar: lookup
        6. Marycz K, Michalak I, Kocherova I, Marędziak M, Weiss C. The Cladophora glomerata Enriched by Biosorption Process in Cr(III) Improves Viability, and Reduces Oxidative Stress and Apoptosis in Equine Metabolic Syndrome Derived Adipose Mesenchymal Stromal Stem Cells (ASCs) and Their Extracellular Vesicles (MV's). Mar Drugs 2017 Dec 8;15(12).
          doi: 10.3390/md15120385pubmed: 29292726google scholar: lookup
        7. Morgan R, Keen J, McGowan C. Equine metabolic syndrome. Vet Rec 2015 Aug 15;177(7):173-9.
          doi: 10.1136/vr.103226pubmed: 26273009google scholar: lookup
        8. Loos C, Castelein A, Vanzant E, Adam E, McLeod KR. Nutraceutical Supplement Mitigates Insulin Resistance in Horses with a History of Insulin Dysregulation During a Challenge with a High-Starch Diet. Animals (Basel) 2024 Nov 25;14(23).
          doi: 10.3390/ani14233385pubmed: 39682351google scholar: lookup
        9. Tomal A, Szłapka-Kosarzewska J, Mironiuk M, Michalak I, Marycz K. Arthrospira platensis enriched with Cr(III), Mg(II), and Mn(II) ions improves insulin sensitivity and reduces systemic inflammation in equine metabolic affected horses. Front Endocrinol (Lausanne) 2024;15:1382844.
          doi: 10.3389/fendo.2024.1382844pubmed: 38689728google scholar: lookup